Evaluation of in vitro wound healing efficacy of breadfruit derived starch hydrolysate


Citation

Yeap S. K., . and Koh S. P., . and Nur Syazwani Abdul Hamid, . and Zahiah Mohamed Amin, . and Tan C. P., . and Kamariah Long, . Evaluation of in vitro wound healing efficacy of breadfruit derived starch hydrolysate. pp. 1771-1781. ISSN 2231-7546

Abstract

To study the wound healing efficacy of breadfruit starch hydrolysate an in vitro wound scratch assay was conducted in which the migration rate of wounded NIH 3T3 fibroblasts was determined. Wounds treated with lower dextrose equivalent (DE) (DE 10-14) starch hydrolysate were found capable to improve the wound healing of NIH 3T3 fibroblast cell with the percentage of wound closure improvement of 77 respectively when compared with higher DE range (DE 15-19 and DE 20-24). The findings obtained in the BrdU uptake and MTT viability assays confirmed the wound healing properties of breadfruit starch hydrolysate as the starch hydrolysate-treated wounded NIH 3T3 fibroblasts were able to proliferate well and no cytotoxicity was observed. Together these findings indicated that the newly developed breadfruit starch hydrolysate performed better than commercial (COM) starch hydrolysate of the same DE ranges. In conclusion breadfruit starch hydrolysate had better functional properties than did starch hydrolysates derived from other sources and that they could play a beneficial role in wound healing applications.


Download File

Full text available from:

Abstract

To study the wound healing efficacy of breadfruit starch hydrolysate an in vitro wound scratch assay was conducted in which the migration rate of wounded NIH 3T3 fibroblasts was determined. Wounds treated with lower dextrose equivalent (DE) (DE 10-14) starch hydrolysate were found capable to improve the wound healing of NIH 3T3 fibroblast cell with the percentage of wound closure improvement of 77 respectively when compared with higher DE range (DE 15-19 and DE 20-24). The findings obtained in the BrdU uptake and MTT viability assays confirmed the wound healing properties of breadfruit starch hydrolysate as the starch hydrolysate-treated wounded NIH 3T3 fibroblasts were able to proliferate well and no cytotoxicity was observed. Together these findings indicated that the newly developed breadfruit starch hydrolysate performed better than commercial (COM) starch hydrolysate of the same DE ranges. In conclusion breadfruit starch hydrolysate had better functional properties than did starch hydrolysates derived from other sources and that they could play a beneficial role in wound healing applications.

Additional Metadata

[error in script]
Item Type: Article
AGROVOC Term: Breadfruit (tree)
AGROVOC Term: Starch hydrolysate
AGROVOC Term: In vitro
AGROVOC Term: Wounds
AGROVOC Term: Healing
AGROVOC Term: Artocarpus altilis
AGROVOC Term: Dextrose
AGROVOC Term: Hydrolysis
AGROVOC Term: Boiling
AGROVOC Term: Polymers
Geographical Term: Malaysia
Depositing User: Ms. Suzila Mohamad Kasim
Last Modified: 28 Apr 2025 05:28
URI: http://webagris.upm.edu.my/id/eprint/23811

Actions (login required)

View Item View Item